Astrid Liedert Person-Info 

( Ich bin Astrid Liedert)

News

Cellmid : Notes to Appendix 4C | MarketScreener

www.marketscreener.com
ASX ANNOUNCEMENT NOTES TO APPENDIX 4C SYDNEY, Monday, 31 October 2016: Cellmid Limited provides the following Notes...

Cellmid Limited (ASX:CDY) New Publication and Patent Application For...

www.abnnewswire.net
The study was led by Dr Astrid Liedert at the Institute of Orthopedic Research and Biomechanics, University Medical Center Ulm, Germany and the results were ...

Cellmid partner in large scale manufacture of drug-like MK for...

www.proactiveinvestors.com
Animal studies by Dr Astrid Liedert at the University of Ulm, Germany, have also shown its anti-MK antibodies enhancing bone fracture healing in vivo.
Dossier exportieren
+1